Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-arm, Randomised, Assessor-blind, Parallel Group Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) and Relvar® Ellipta® DPI on Ventilation Heterogeneity in Subjects With Partially Controlled or Uncontrolled Asthma

NCT02753712 is registered in ClinicalTrials.gov with Mundipharma Research Limited as lead sponsor.

NCT NCT02753712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02753712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-arm, Randomised, Assessor-blind, Parallel Group Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) and Relvar® Ellipta® DPI on Ventilation Heterogeneity in Subjects With Partially Controlled or Uncontrolled Asthma
Lead sponsor
Mundipharma Research Limited
Phase
Phase 3
Overall status
Completed
Start date
June 15, 2016
Completion date
August 14, 2017
Enrollment
105 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

asthma